Abstract GM1 ganglioside (II 3 NeuAc-Gg 4 Cer) is known to promote neurite formation in neuroblastoma cells by activating TrkA-MAPK pathway. The molecular mechanism by which GM1 is involved in the neurodifferentiation process is still unknown, however, in vitro and in vivo evidences have suggested that the oligosaccharide portion of this ganglioside could be involved. Here, we report that, similarly to the entire GM1 molecule, its oligosaccharide II 3 NeuAc-Gg 4, rather than its ceramide (Cer) portion is responsible for the neurodifferentiation process by augmenting neurite elongation and increasing the neurofilament protein expression in murine neuroblastoma cells, Neuro2a. Conversely, asialo-GM1, GM2 and GM3 oligosaccharides are not effective in neurite elongation on Neuro2a cells, whereas the effect exerted by the Fuc-GM1 oligosaccharide (IV 2 aFucII 3 Neu5Ac-Gg 4 ) is similar to that exerted by GM1 oligosaccharide. The neurotrophic properties of GM1 oligosaccharide are exerted by activating the TrkA receptor and the following phosphorylation cascade.
Gangliosides, glycosphingolipids containing sialic acid, constitute a wide family whose components differ in the structure of both the oligosaccharide and lipid chains (Sonnino et al. 2006) . They are typical components of neuronal membranes taking place with a 10-fold higher amount than in non-neuronal cells and presenting oligosaccharide chains that contain up to five residues of sialic acid. Their change in concentration during brain development suggests specific roles in the nervous system (Allende and 1 These authors contributed equally to this work. Ganglioside nomenclature is in accordance with IUPAC-IUBB recommendations (IUPAC-IUMBMB 1998) .
Abbreviations used: AGM1, tetrahexosylceramideGg 4 ; DMEM, Dulbecco's modified Eagles' medium; ERK1/2, extracellular signalregulated protein kinases 1 and 2; FBS, fetal bovine serum; Fucosylated GM1 oligosaccharide, IV 2 aFucII 3 Neu5Ac-Gg 4 ; GM1 oligosaccharide, II 3 Neu5Ac-Gg 4 ; GM1, II 3 Neu5Ac-Gg 4 Cer, b-Gal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-3)]-b-Gal-(1-4)-b-Glc-Cer; GM2 oligosaccharide, II 3 Neu5Ac-Gg 3 ; GM3 oligosaccharide, sialyllactose; HPTLC, highperformance silica gel thin-layer chromatography; MAPK, mitogenactivated protein kinase; MTT, 3-(4,5,-dimethylthiazole-2yl)-2,5-diphenyltetrazolium bromide; N2a, Neuro2a cells; NF, neurofilament; NGF, nerve growth factor; PBS, phosphate-buffered saline; p-ERK1/2, phosphorylated ERK1/2; PM, plasma membrane; p-TrkA, phosphorylated TrkA; PVDF, polyvinylidene difluoride; siRNA, short interfering RNA; Trk, neurotrophin tyrosin kinase receptor; Tyr490, tyrosine 490; a-tub, a-tubulin. Panzetta 1994; Wu et al. 1995; Kwak et al. 2005; Yu et al. 2009; Aureli et al. 2011) . Particular attention has been devoted to ganglioside GM1, II 3 NeuAc-Gg 4 Cer (Ledeen and Wu 2015; Schengrund 2015; Aureli et al. 2016) , structurally characterized by the oligosaccharide chain II 3 NeuAc-Gg 4 , bGal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-3)]-b-Gal-(1-4)-bGlc- (Kuhn and Wiegandt 1963) . In vitro and in vivo approaches highlighted the neurotrophic and neurodifferentiative functions of ganglioside GM1 (Roisen et al. 1981; Facci et al. 1984; Chigorno et al. 1985; Lipartiti et al. 1991; Rodriguez et al. 2001; Da Silva et al. 2005; Mocchetti 2005; Schneider et al. 2010; Sonnino et al. 2011; Miyagi and Yamaguchi 2012) . The effects exerted by GM1 occur when its plasma membrane (PM) content increases in membrane lipid micro-domains (Hakomori et al. 1998) . The membrane local enrichment causes (i) the GM1 contentdependent membrane reorganization, which alters membrane properties and ensures the physical parameters required for proper protein function or (ii) the GM1 oligosaccharideprotein direct interactions, which modify the protein conformation and function (Coskun and Simons 2011) .
The plasma membrane increase of GM1 is responsible for the activities of several membrane enzyme and receptor (Tettamanti 1986; Zoli et al. 1990) . In fact, membraneassociated proteins, including neurotrophin receptors, opioid receptors, integrins and calcium transporter, have been proposed as interactor partners of GM1 (Ledeen and Wu 2015) . In particular, interaction between GM1 and the neurotrophin tyrosin kinase receptor (Trk) has been claimed for modulation of neuritogenesis (Ferrari et al. 1995; Mutoh et al. 1995; Farooqui et al. 1997; Bachis et al. 2002) . As described by different authors, plasma membrane increase of GM1 and formation of a GM1 enriched platform leads to membrane reorganization triggering to the dimerization of TrK, followed by its autophosphorylation (Rodriguez et al. 2001; Da Silva et al. 2005) .
In spite of many papers, connect the neurite elongation with GM1 plasma membrane content and with modulation of the Trk activity, the precise GM1 mechanism of action remains elusive. Opposite experimental approaches, such as the PM sialidase NEU3 over-expression, but also its inhibition, led to think that changes in oligosaccharidic chains of plasma membrane gangliosides could affect the fine tuning of the processes through the plasma membrane (Rodriguez et al. 2001; Valperta et al. 2007) . However, only few data concerning the relationship between ganglioside oligosaccharide and neuritogenesis processes have been reported so far (Schengrund and Prouty 1988) . For this reason, we decided to investigate the role played by the oligosaccharide chain of GM1 and we found out that the GM1 oligosaccharide is able to promote the TrkA-dependent neurite sprouting in mouse neuroblastoma cells.
Methods

Materials
Commercial chemicals were of the highest purity available, common solvents were distilled before use and water was doubly distilled in a glass apparatus.
Cell culture plates and Transfectagro TM reduced serum medium were from Corning (Corning, NY, USA). Mouse neuroblastoma Neuro2a (N2a) cells (RRID: CVCL_0470), phosphate-buffered saline (PBS), Paraformaldehyde, Triton X-100, sodium dodecyl sulfate (SDS), 2-propanol, Formic acid, 3-(4,5,-dimethylthiazole-2yl)-2,5-diphenyltetrazolium bromide (MTT), Trypan blue, Galactose, Sialic Acid, anti-rabbit FITC conjugate, and mouse a-tubulin antibodies were from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco's modified Eagle's high glucose medium, fetal bovine serum (FBS), L-glutamine (L-Glut), Penicillin (10.000 U/mL), Streptomycin and 30% acrylamide were from EuroClone (Paignton, UK 
Preparation of gangliosides and their oligosaccharides
Fuc-GM1 (Ghidoni et al. 1976) , GM1 and GM2 gangliosides were purified from the total ganglioside mixture extracted from pig brains (Tettamanti et al. 1973) , submitted to sialidase hydrolysis (Acquotti et al. 1994) . Desialylated GM1 (AGM1, asialo-GM1) was prepared by acid hydrolysis of GM1 and chromatographic purification (Ghidoni et al. 1976) . GM1 containing tritium at position 6 of external galactose was prepared by enzymatic oxidation with galactose oxidase followed by reduction with sodium boro[ 3 H]hydride (Sonnino et al. 1996) (Lubineau et al. 1995) .
The crude amino-II 3 Neu5Ac-[ 3 H]Gg 4 was dissolved in 0.5 mL of dry dimethylformamide, then 1 mg of 2-nitro-4-fluorophenylazide and 1 lL of tributylamine in 25 lL of dry dimethylsulfoxide were added under dark conditions. Maintaining dark conditions for all the process, the reaction mixture was stirred overnight at 80°C. After solvent evaporation, the photoactivable II HPTLC analyses were performed using the solvent system chloroform/methanol/0.2% CaCl 2 , 60 : 35 : 8 by vol. Bound sialic acid was determined by the resorcinol-HCl method (Svennerholm 1957; Takki-Luukkainen and Miettinen 1959) , pure Neu5Ac being used as the reference standard.
Cell cultures
N2a cells were cultured and propagated as monolayer in Dulbecco's modified Eagle's medium-High Glucose medium supplemented with 10% heat inactivated FBS, 1% L-glutamine and 1% penicillin/ streptomycin, at 37°C in a humidified atmosphere of 95% air/5% CO 2 . Cells were subcultured to a fresh culture when growth reached the 80-90% confluence (i.e. every 3-4 days).
Cell treatments N2a cells were plated at 5 9 10 3 /cm 2 and incubated for 24 h to allow cells attachment and recovery in complete medium before all treatments. Control cells were incubated under identical conditions but omitting any addition.
Ganglioside and oligosaccharide treatments
To induce differentiation, growth medium was removed and cells were pre-incubated in pre-warmed (37°C) Transfectagro medium containing 2% FBS, 1% L-glutamine, 1% penicillin/streptomycin, for 30 min at 37°C. Cell treatments were performed in serum reduced culture medium, in order to minimize interactions between serum components and exogenous gangliosides or their oligosaccharides. Subsequently, cells were incubated at 37°C up to 48 h in the presence of 50 lM gangliosides, oligosaccharides, galactose, or sialic acid.
TrkA chemical inhibition experiments
In order to block TrkA activity in N2a cells, the TrkA inhibitor (120 nM) was added to the incubation medium 1 h before the addition of GM1 or II 3 Neu5Ac-Gg 4 (Wood et al. 2004) .
siRNA mediated RNA interference experiments TrkA knockdown was achieved by RNA interference applying siRNA. Three distinct siRNAs were used to silence TrkA: Mm_Ntrk1_1 (sense
As a negative control, non-silencing siRNA with no homology to any known mammalian gene was used (sense 5 0 -UUCUUCGAACGUGU
. Transfection was performed after 24 h from cell plating in antibiotic and serum free culture media with solution containing 25% OptiMEM, 0.25% Lipofectamine 2000 and 50 nM siRNA (16.7 nM of each siRNA). After 6 h, the transfection medium was changed to culture medium containing antibiotic and serum. After 24 h from the silencing, cells were treated with GM1 or II 3 Neu5Ac-Gg 4 as above.
Photolabeling experiments Cells were incubated with 50 lM II 3 Neu5Ac-[ 3 H]Gg 4 -N 3 for 3 h at 37°C. After incubation, medium was removed and cells were illuminated for 40 min under UV light (k = 360 nm) on ice to induce photo-activation. All the procedures before exposure to UV light were performed under red safelight. The cells were lyzed and subjected to 4-20% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted on PVDF membrane. Digital autoradiography of the PVDF membrane was performed with Beta-Imager 2000 (Biospace, Paris, France). PVDF membrane was then incubated with anti-TrkA antibody (Sonnino et al. 1989 (Sonnino et al. , 1992 Chigorno et al. 1990; Loberto et al. 2003; Chiricozzi et al. 2015) .
Determination of cell viability
Cell viability was determined by Trypan blue exclusion and by MTT assays after 12, 24 and 48 h treatment with gangliosides and oligosaccharides. The number of living and death cells has been determined by counting cells after Trypan blue staining, as previously described (Mehlen et al. 1988; Aureli et al. 2011) . Proliferation was determined by the MTT method (Mosmann 1983) . Briefly, at the end of incubation, 2.4 mM MTT (4 mg/mL in PBS) were added to each well and plates were re-incubated for 4 h at 37°C. Medium was carefully removed and replaced with 2-propanol: formic acid, 95 : 5 (v/v). Plates were gently agitated prior to read the absorbance at 570 nm with a microplate spectrophotometer (Wallac 1420 VICTOR2 TM ; Perkin Elmer).
Morphological analysis and neurite outgrowth evaluation
Cultured cells treated with ganglioside GM1 or different oligosaccharides were observed by phase contrast microscopy (Olympus BX50 microscope; Olympus, Tokyo, Japan). The neurite-like length was measured on bidimensional images and expressed as the ratio between neurite length and cell body diameter (Schengrund and Prouty 1988). Five random fields were examined from each well, giving a total cell count of at least 200 cells per well.
Immunofluorescence analysis
Treated or not treated cells were fixed in 4% paraformaldehyde for 20 min at 23°C. Cells were permeabilized with 0.1% Triton X-100 for 30 min and then treated with a blocking solution for 1 h at 23°C. Cells were incubated with rabbit polyclonal antibody anti-NF for 2 h at 23°C. After washing with PBS, cells were incubated 1 h with secondary anti-rabbit antibody FITC-conjugated. Fluorescence microscopy was carried out using an Olympus U-RFL-T EPI Fluorescence Microscope (Olympus) and the images processing were performed with ImageJ software.
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Protein analysis
Equal amounts of proteins derived from treated and untreated cells were denatured, separated on 7.5% polyacrylamide gels, and transferred to PVDF membranes. The presence of NF, TrkA, p-TrkA, extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) and p-ERK1/2 was determined by specific primary antibodies, followed by reaction with secondary horseradish peroxidase-conjugated antibodies. a-tubulin was used as loading control. The data acquisition and analysis were performed using Alliance Uvitec (Eppendorf, Germany).
Molecular modeling
Crystallographic structure of the extracellular segment of human TrkA in complex with nerve growth factor (NGF) (RCSB PDB ID: 2IFG) was used for molecular docking calculations. Protein complex was submitted to the Molecular Operating Environment 2016.0802 (MOE) Structure Preparation application, in order to fix all issues and to prepare structures for subsequent computational analyses.
The II 3 Neu5Ac-Gg 4 structure was built with the MOE Carbohydrate Builder and a geometry optimization was carried out with MOPAC7 and the PM6 basis set.
Molecular docking was carried out through the MOE Dock program, setting as receptor the complex between TrkA and NGF, as ligand the optimized II 3 Neu5Ac-Gg 4 structure. The binding site was identified at the interface between the two proteins. Before placement procedure, 20 000 rotamers of the ligand was generated, exploring all the molecule rotatable bonds. Alpha PMI placement algorithm, specifically developed for tight binding pocket, was selected. The London dG empirical scoring function was used for sorting the poses. The 30 top-scoring poses was refined through molecular mechanics, considering the receptor as a rigid body, and the refined complexes were scored through the GBVI/WSA dG empirical scoring function, keeping the five top-scoring poses.
The top-scoring pose from the docking procedure was refined by using the MOE QuickPrep procedure aimed at relaxing and refining the complex before calculating the approx. binding free energy via the GBVI/WSA dG empirical scoring function (Naim et al. 2007 ).
Statistical analysis
Data are expressed as mean AE SEM and were analyzed for significance by Student's t-test or two-way ANOVA test. The analysis was performed with Prism software (GraphPad Software, Inc. La Jolla, CA, USA).
Other analytical methods NMR spectra were recorded with a Bruker AVANCE-500 spectrometer at a sample temperature of 298 K. NMR spectra were recorded in CDCl3 or CD3OD and calibrate using the TMS signal as internal reference.
Mass spectrometric analysis were performed in positive or negative ESI-MS. MS spectra were recorded on a Thermo Quest Finningan LCQTM DECA ion trap mass spectrometer, equipped with a Finnigan ESI interface; data were processed by Finnigan Xcalibur software system (Thermo Fischer Scientific, Waltham, MA, USA).
All reactions were monitored by TLC on silica gel 60 plates (Merck). Radioactivity associated with cells and trypsin and serum labile cell fractions was determined by liquid scintillation counting. Digital autoradiography of the PVDF membranes was performed with a Beta-Imager 2000 (Biospace).
Any randomization or blinding procedures were performed for our experiments. Institutional approval was not needed.
Results
N2a cell viability upon treatments with ganglioside GM1 and its oligosaccharide Trypan blue assay, performed on N2a cells treated with 50 lM GM1 ganglioside or its oligosaccharide up to 48 h, showed a viability overlapping to that of control cells and over 94% (Fig. 2a) . On the other hand, we observed a reduction in cell proliferation starting from 12 h of treatment (Fig. 2b) .
Neurite sprouting by administration to N2a cells of II 3 Neu5Ac-Gg 4
Incubation of N2a cells with II 3 Neu5Ac-Gg 4 induced a neuron-like morphology after 24 (Fig. 3 ) and 48 h (Figure S1 ), pointing out the sprouting and elongation of neurites, which are almost absent in round-shaped control cells. A similar result was obtained in cells treated with GM1, confirming previous data (Facci et al. 1984 ; Rabin et al. ). N2a cells were treated with Gg 4 , II 3 Neu5Ac-Gg 3 , sialyllactose, galactose, or sialic acid in order to clarify the minimal structure required to promote neurite elongation. None of these compounds induced cell morphological changes (Fig. 3 and Figure S1 ), suggesting that the whole structure of the II 3 Neu5Ac-Gg 4 is necessary to block cell proliferation and to induce neurite sprouting. In addition, cells were treated with fucosylated II 3 Neu5Ac-Gg 4 , which induces neurite sprouting and reduction of cell proliferation in a similar way as II 3 Neu5Ac-Gg 4 . This result suggests that the neurite sprouting process requires specifically the b-Gal-(1-3)-b-GalNAc-(1-4)-[a-Neu5Ac-(2-3)]-b-Gal-(1-4)-Glc structure and that the addition to it of an a-fucose at position 2 of the external galactose is irrelevant for the processes (Fig. 3 and Figure S1 ).
Neurite extensions, observed after 24 h treatment with II 3 Neu5Ac-Gg 4 , were measured as the ratio between the length of processes and the diameter of cell body (Fig. 4a) . This ratio resulted at least two fold higher compared to the control and similar to GM1-treated cells.
Expression of heavy, medium, and light intracellular NF subunits (NF-H, NF-M and NF-L), considered markers of neurodifferentiation (Fukuda et al. 2014) , was evaluated by immunoblotting. NF proteins are considered the major components of cytoskeleton supporting axonal construction. NF expression increased significantly after 24 h treatment with both GM1 and II 3 Neu5Ac-Gg 4 (Fig. 4b) , resulting quite evident by immunofluorescence (Fig. 4c) . Neu5Ac-Gg 4 was administered to the N2a cells. After 0.5, 1, 6, and 24 h treatment, cells were treated according to a procedure previously developed (Chigorno et al. 1985) . At the end of the incubation, cells were washed with culture medium containing 10% serum in order to evaluate the quantity of oligosaccharide weakly associated to the cells surface (serum labile). Successively cells were treated with trypsin to evaluate a possible portion strongly bond to the extracellular domain of PM proteins (trypsin labile). At the end, cells were lyzed in order to evaluate the quantity of internalized II Neu5Ac-Gg 4 in the GM1-promoted TrkA activation. In detail, we focused on phosphorylation of Tyr490, which leads to the activation of the neuronal differentiation pathway (Singleton et al. 2000; Duchemin et al. 2002; Huang and Reichardt 2003; Zakharova et al. 2014) . By immunoblotting analysis, we highlighted the activation of TrkA receptor revealed by the increase in the phosphorylation of Tyr490 either in GM1-treated cells and in cells that received II 3 Neu5Ac-Gg 4 (Fig. 6a) . In the treated cells, we also checked the activation of MAP kinases founding an increase of ERK1/2 phosphorylation (Fig. 6a) . To prove that the neuritogenic effect exerted by the GM1 or its oligosaccharide was directly mediated by TrkA-ERK pathway, we blocked the TrkA receptor by chemical inhibition, using a specific TrkA inhibitor, able to fit in the ATP pocket (Wood et al. 2004 ). The addition of TrkA inhibitor together with the GM1 or the II 3 Neu5Ac-Gg 4 prevented the phosphorylation processes (Fig. 6a ) and the neurite elongation (Fig 6b) .
Furthermore, to prove the necessary requirement of TrkA in II 3 Neu5Ac-Gg 4 -mediated neuritogenesis, TrkA was knocked down using the siRNA approach. Control cells were transfected with scramble-siRNA. Silenced cells, resulting in a 70% reduction of TrkA expression (Fig. 7a) , were incubated with GM1 or II 3 Neu5Ac-Gg 4 for 24 h and no differentiation, nor the phosphorylation of Erk1/2 (Fig. 7b and c) could be observed.
II 3 Neu5Ac-Gg 4 -TrkA interaction in N2a cells
To study the interaction between the oligosaccharide chain of GM1 and TrkA, we prepared, according to the scheme in Fig. 1 under dark conditions. After pulse, cells were illuminated under UV-light to induce covalent cross-linking between cell surface proteins and the radioactive GM1 oligosaccharide derivative. Proteins were separated by SDS-PAGE, blotted on a PVDF membrane and the radioactive bands visualized by digital autoradiography. In comparison to N2a protein pattern, few radioactive bands were detected. They correspond to specific proteins that, after the illumination, are covalently bond with II 3 Neu5Ac-Gg 4 (Fig. 8) . After radioimaging, the PVDF membrane was incubated with TrkA antibody and we could detect a specific TrkA signal co-migrating with the radioactive band at 140 kDa visualized by the digital autoradiography (Fig. 8) . Neu5Ac-Gg 4 complex The availability of the crystallographic structure of the extracellular segment of human TrkA in complex with NGF allowed us to support biochemical data with bioinformatics. The molecular docking of II 3 Neu5Ac-Gg 4 , specifically carried out exploring the interaction interface between TrkA and NGF, showed that II 3 Neu5Ac-Gg 4 is able to tightly bind both TrkA and NGF contemporarily, producing only one very stable pose, with an approximative binding free energy of À11.3 kcal/mol (Fig. 9) .
Discussion
Gangliosides are components of the external layer of plasma membranes where they represent about one-sixth of the total lipid content. In addition to their structural role, they are considered players in signaling and regulatory pathways. The chemical structure of gangliosides makes them ideal mediators of information across the plasma membrane: the ceramide portion allows hydrophobic interactions inside the membrane core, the ceramide amide linkage leads to the formation of a net of hydrogen bonds at the water-lipid interface and the oligosaccharide facing toward the extracellular environment provides specific side-to-side and head-tohead recognition sites. These properties favor formation of lipid rafts, segregation of proteins and ganglioside-protein interactions, which lead to cell function modulation.
GM1 is the best-studied neuronal ganglioside. Its properties, such as modulation of differentiation, adhesion, migration, neurotrophic factor signaling, axon guidance, synaptic transmission, myelin genesis, and neuron-glia interactions have been described, and continue to be confirmed in several papers (see recent reviews Schengrund 2015; Ledeen and Wu 2015; Aureli et al. 2016) .
GM1-mediated neurodifferentiation has been studied by in vitro and in vivo experiments (Facci et al. 1984; Lipartiti et al. 1991; Rodriguez et al. 2001; Da Silva et al. 2005; Mocchetti 2005) , but the precise molecular mechanism by which GM1 exerts its neurotrophic action is still unclear. Anyhow, the increase of GM1 within the plasma membrane seems to be necessary for TrkA-mediated neurodifferentiative processes; in fact the lack of GM1 caused unresponsiveness of the TrkA protein to NGF (Facci et al. 1984; Mutoh et al. 1998) .
Here, we presented a specific role of GM1 oligosaccharide, a part from the entire ganglioside, in the process of neurite elongation in murine neuroblastoma N2a cells. This line of evidence suggests that ceramide acts as an aglycone, dynamically moving within the membrane layer and allowing different carbohydrate-protein interactions that are dependent on ganglioside content and membrane organization.
For our experiments, we prepared the GM1 oligosaccharide, its tritiated form and its tritiated-and-photoactivable form. The GM1 oligosaccharide was prepared by chemical ozonolysis of pure GM1 followed by alkaline fragmentation according to an old procedure capable to give very high yield (Wiegandt and Bucking 1970) . Chromatography and MS analyses showed that the GM1 oligosaccharide was pure and devoid of GM1 ( Figure S2 ). The same procedure was applied to a GM1 carrying tritium at the C6 position of external galactose to obtain II 3 Neu5Ac-[ 3 H]Gg 4 , part of which was derivatized with nitro-phenyl-azide to prepare a tritium-labeled and photoactivable II 3 Neu5Ac-Gg 4 (Fig. 1) . II 3 Neu5Ac-Gg 4 was added to cell culture medium to obtain a 50 lM concentration. The II 3 Neu5Ac-Gg 4 associated to the cell surface could be completely detached from the cells by washing cells with protein solutions (Fig. 5) . No detectable amount of II 3 Neu5Ac-Gg 4 was taken up by the cells. This suggests that the II 3 Neu5Ac-Gg 4 associated with the surface remains in equilibrium with the free soluble form. The association of II 3 Neu5Ac-Gg 4 to N2a cells reduced cell proliferation, with no changes in cell viability (Fig. 2) , and rapidly produced neurite sprouting (Fig. 3 and Figure S1 ). The neurite elongation goes together with the increase of neurofilament protein expression (Fig. 4) . The neurite sprouting and the expression of neurofilaments are markers of neuronal differentiation (Fukuda et al. 2014) , and we conclude that the effect exerted by II 3 Neu5Ac-Gg 4 on N2a cells overlaps to that previously reported for ganglioside GM1 (Facci et al. 1984) . Moreover, we demonstrated that the effect exerted by II 3 Neu5Ac-Gg 4 was structure-specific. In fact, residues of the total structure, such as sialic acid, galactose, sialyllactose, Neu5Ac-Gg 3 and Gg 4 , did not show neuritogenic properties, at least at the used concentration ( Fig. 3 and Figure S1 ). On the other hand, fucosylated II 3 Neu5Ac-Gg 4 showed the same effect of II 3 Neu5Ac-Gg 4 suggesting that the terminal a-Fuc-(1-2)-b-Gal linkage does not change the conformation of the Neu5Ac-Gg 4 necessary for the activation of the sprouting process ( Fig. 3 and Figure S1 ). This evidence agrees with the previous information reporting that GM1 and Fuc-GM1 show similar binding constant for cholera toxin (Masserini et al. 1992) .
It has been reported that nerve growth factor receptor TrkA requires the presence of GM1-enriched membrane to be active, while the absence of ganglioside GM1 is negatively correlated with TrkA function (Ferrari et al. 1995; Mutoh et al. 1995 Mutoh et al. , 1998 Farooqui et al. 1997; Rodriguez et al. 2001; Bachis et al. 2002; Da Silva et al. 2005) . TrkA phosphorylation at Tyr490 residue induces the phosphorylation cascade as shown in Fig. 10 (Huang and Reichardt 2003; Brodeur et al. 2009 ). Previous finding revealed the activation of the TrkA-Erk1/2 pathway by ganglioside GM1 (Farooqui et al. 1997; Singleton et al. 2000; Duchemin et al. 2002; Zakharova et al. 2014) . Thus, we studied the TrkA-Erk1/2 pathway following the addition of II 3 Neu5Ac-Gg 4 to N2a. For the first time, we showed that, II 3 Neu5Ac-Gg 4 enhances the phosphorylation of Tyr490 of TrkA and of Erk1/2 leading to neurodifferentiation (Fig. 6) . To confirm that the GM1-TrkA interaction triggers the differentiation, we silenced or inhibited TrkA. In both experiments, the addition of II 3 Neu5Ac-Gg 4 to the cells did not promote neurite sprouting nor reduced the cell proliferation (Figs 6 and 7) .
These findings support that the well-known GM1 neurotrophic effects are mediated by TrkA receptor, which could be considered an II 3 Neu5Ac-Gg 4 target. To obtain evidence about the formation of an II 3 Neu5Ac-Gg 4 -TrkA complex, we prepared a tritium-labeled photoactivable II 3 Neu5Ac-Gg 4 by chemical techniques (Fig. 1) . Photolabeling experiments with photoactivable glycosphingolipids were introduced several years ago (Loberto et al. 2003; Mauri et al. 2004 ) and were used to ascertain the interaction of glycosphingolipids with different proteins, such as the insulin receptor (Kabayama et al. 2007) , the receptor CD9 (Ono et al. 2001) , the cytoskeleton tubulin (Palestini et al. 2000) , the membrane protein caveolin 1 (Fra et al. 1995) , the kinase Lyn (Chiricozzi et al. 2015) , and the neuronal protein TAG1 (Loberto et al. 2003) .
After incubation with the tritium-labeled photoactivable II 3 Neu5Ac-Gg 4 , cells were washed once with PBS to remove the non-cell-associated compound. The subsequent UV-light exposition transforms the photoactivable group into a nitrene, which rapidly covalently links to neighboring compounds (Mauri et al. 2004) . According to this mechanism, and recalling that the exogenous II 3 Neu5Ac-Gg 4 does not become component of the cell membranes, any interaction of the tritium-labeled II 3 Neu5Ac-Gg 4 photoactivable derivative with proteins yields to tritium-labeled II 3 Neu5Ac-Gg 4 -protein stable complexes that should involve the extracellular domain of transmembrane proteins or of GPI-anchored proteins. By SDS-PAGE separation, followed by radioimaging of the blotted material, we recognized few bands and one of these bands showed a molecular mass of 140 KDa. A specific signal for TrkA was found overlapping the radiolabeled band, suggesting a direct interaction between II 3 Neu5Ac-Gg 4 and TrkA (Fig. 8) . Over these experimental data, we used molecular modeling tools to predict whether II 3 Neu5Ac-Gg 4 can increase the TrkA-NGF complex stability, favoring their intermolecular interactions. In fact, even if NGF is not synthetized by N2a cells (Leon et al. 1994) , it is present in our experimental conditions since the culture medium used contains serum ( Figure S3 ). We started from the crystallized structure of TrkA receptor, which is resolved as a dimer in the presence of NGF. The crystal structure of the TrkA-NGF complex is characterized by a pocket, which can be occupied by water molecules, as showed in another crystallographic structure of the same complex (PDB ID: 1WWW). By in silico analysis, we found that the II 3 Neu5Ac-Gg 4 perfectly fits within this space (Fig. 9) . Moreover, the energy associated to the TrkA-II 3 Neu5Ac-Gg 4 complex, approx. À6.6 kcal/mol, becomes approx. À11.5 kcal/mol when NFG belongs to the complex. This suggests that the II 3 Neu5Ac-Gg 4 stabilizes the TrkA-NGF interaction, and suggests a specific molecular recognition process between the II 3 Neu5Ac-Gg 4 and a specific extracellular domain of the TrkA receptor.
The information available in literature clearly shows that any experimental model capable to modify the local plasma membrane GM1 content, promotes N2a differentiation. GM1 is a natural amphiphilic compound with a structure that combines the ceramide lipid moiety with the soluble oligosaccharide chain. Altogether, our results point out that the GM1 oligosaccharide is the structure portion responsible for the neurodifferentiative properties exerted by GM1 (Fig. 10) . The GM1 oligosaccharide directly interacts with TrkA receptor resulting in TrkA-mediated neuritogenesis.
Neuronal differentiation is characterized by an enhancement of several glycosyltransferases activity leading to an increase in PM ganglioside content . Ceramide is the aglycone necessary for glycan protrusion into the extracellular environment and for interaction with functional proteins. GM1 exhibits its oligosaccharide chain to the TrkA receptor. Molecular dynamic calculations confirm that the GM1 oligosaccharide perfectly fits with a TrkA domain stabilizing the TrkA-NGF interaction, allowing a rapid auto phosphorylation of the receptor cytosolic portion.
The still open question is whether the II 3 Neu5Ac-Gg 4 -TrkA interaction is due to a broad plasma membrane increase of GM1 or to a membrane reorganization, leading to a new TrkA environment enriched of GM1. We reported this latter possibility because silencing plasma membrane sialidase Neu3, with consequent less hydrolysis of polysialylated gangliosides and with reduced production of GM1 at the plasma membrane level, we promoted the neurite elongation (Valperta et al. 2007 ). We discussed this in term of membrane reorganization and local concentration of GM1.
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